There is often some confusion around the concept of family business. A lot of people think they have a private business and don’t consider themselves to have a ‘family business’, but there is a big difference between the two.
Zeiss Eyewear’s new Architekt range has won the prestigious German Design Award for excellent product design in the lifestyle and fashion category.
Vivior has developed the Visual Behaviour Monitor - AI software that recognises and matches individual’s visual behaviour data with available intraocular lenses to optimise lens selection for
This year’s Silmo, the quintessential European optical show, promises to be a dynamic one, say organisers, with 92% of objectives achieved five months prior to the show’s opening and more than 53,900 attendees expected to visit more than 1,650 exhibitors from across the world.
Innovative eye care technology enterprise oDocs has scooped a major US$100,000 Dubai World Expo Live Innovation Impact Grant from the United Arab Emirates for research and development work.Company
A Polish study has found there’s no increased risk to patients who didn’t attend a follow up appointment in person the day after having standard phacoemulsification cataract surgery (PCS).
Scientists have 3D printed an artificial cornea made from a bioink of decellularised corneal stroma and stem cells, which has a similar transparency to a human cornea.
Professor Helen Danesh-Meyer, the Sir William and Lady Stevenson professor of ophthalmology at Auckland University and chair of Glaucoma New Zealand, is the first New Zealander to be invited to give the international keynote address at the American Society of Cataract and Refractive Surgery’s (ASCRS
Fourth year medical student Waldir Rodrigues De Souza Jr from the University of Otago, was introduced as the latest Gordon Sanderson scholar at the 2019 RANZCO NZ conference for his research into applying artificial intelligence (AI) to detect glaucoma.
A trial using recombinant human nerve growth factor (rhNGF) eye drops to treat dry eye disease has had promising results.
Major funding from a coalition of American philanthropists is being fast-tracked to develop a simple eye test to detect early signs of Alzheimer’s disease.
Researchers at Columbia University have developed a new approach to deliver drugs safely to precise locations in the brain using ultrasound and microbubbles injected into the blood stream.The
